Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00150098 · ClinicalTrials.gov registry record · NA
Project UNITY - HIV Risk Reduction and Vaccine Education Interventions
A NA study, sponsored by New York Blood Center.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT00150098 is a NA study that has completed, run by New York Blood Center. The registered enrollment target is 400 participants.
The verdict
NCT00150098, a NA study, has completed, sponsored by New York Blood Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
To determine the efficacy of an enhanced HIV risk reduction intervention delivered concurrently with a vaccination schedule to reduce the number of unprotected vaginal and anal sex acts among HIV-negative, high-risk non-injection drug-using (NIDU) women. To determine the efficacy of an enhanced vaccine education intervention delivered at baseline to increase vaccine knowledge and understanding of a potential HIV vaccine among HIV-negative, high-risk NIDU women.
Interventions
- BEHAVIORAL Enhanced HIV risk reduction and HIV vaccine education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-02 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00150098
The ClinicalTrials.gov registry entry for NCT00150098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Blood Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced HIV risk reduction and HIV vaccine education is the first listed.
NCT00150098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00150098 about?
NCT00150098 is a clinical study titled "Project UNITY - HIV Risk Reduction and Vaccine Education Interventions". To determine the efficacy of an enhanced HIV risk reduction intervention delivered concurrently with a vaccination schedule to reduce the number of unprotected vaginal and anal sex acts among HIV-negative, high-risk non-injection drug-using (NIDU) women. To determine the efficacy of an enhanced vacc...
What is the current status of trial NCT00150098?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2005-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00150098?
The interventions under investigation include: Enhanced HIV risk reduction and HIV vaccine education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00150098?
This trial is sponsored by New York Blood Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.